Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral, transdermal |
ATC code | None |
Legal status | |
Legal status | |
Identifiers | |
|
|
CAS Number | 145-13-1 |
PubChem (CID) | 8955 |
IUPHAR/BPS | 2376 |
DrugBank | DB02789 |
ChemSpider | 8611 |
UNII | 73R90F7MQ8 |
ChEBI | CHEBI:16581 |
ChEMBL | CHEMBL253363 |
ECHA InfoCard | 100.005.135 |
Chemical and physical data | |
Formula | C21H32O2 |
Molar mass | 316.483 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) |
Pregnenolone (P5), or pregn-5-en-3β-ol-20-one, is an endogenous steroid and precursor/metabolic intermediate in the biosynthesis of most of the steroid hormones, including the progestogens, androgens, estrogens, glucocorticoids, and mineralocorticoids. In addition, pregnenolone is biologically active in its own right, acting as a neurosteroid.
Pregnenolone is synthesized from cholesterol. This conversion involves hydroxylation of the side chain at the C20 and C22 positions, with cleavage of the side chain. The enzyme performing this task is cytochrome P450scc, located in the , and controlled by anterior pituitary trophic hormones, such as adrenocorticotropic hormone, follicle-stimulating hormone, and luteinizing hormone, in the adrenal glands and gonads. There are two intermediates in the transformation of cholesterol into pregnenolone, 22R-hydroxycholesterol and 20α,22R-dihydroxycholesterol, and all three steps in the transformation are catalyzed by P450scc.